CHM expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.94755322979745E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.58410000064657E-08 |
Normal-vs-Stage2 |
3.96340000000661E-05 |
Normal-vs-Stage3 |
1.9462209621679E-12 |
Normal-vs-Stage4 |
1.63546953757532E-12 |
Stage1-vs-Stage2 |
3.690800E-01 |
Stage1-vs-Stage3 |
4.820300E-04 |
Stage1-vs-Stage4 |
3.7505999999965E-05 |
Stage2-vs-Stage3 |
1.412020E-01 |
Stage2-vs-Stage4 |
2.890300E-02 |
Stage3-vs-Stage4 |
3.955800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.88005166990024E-12 |
Normal-vs-AfricanAmerican |
1.86672899360474E-12 |
Normal-vs-Asian |
3.393200E-01 |
Caucasian-vs-AfricanAmerican |
8.863800E-03 |
Caucasian-vs-Asian |
3.907400E-01 |
AfricanAmerican-vs-Asian |
2.032000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.38777878078145E-14 |
Normal-vs-Female |
4.71019999670474E-08 |
Male-vs-Female |
1.858470E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.22660000437358E-08 |
Normal-vs-Age(41-60Yrs) |
1.24629995212899E-09 |
Normal-vs-Age(61-80Yrs) |
2.13529194326156E-12 |
Normal-vs-Age(81-100Yrs) |
5.32110000506236E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.505630E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.896800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.999800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.105200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.740420E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.160000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.676040E-01 |
Normal-vs-Grade 2 |
4.04959999977805E-07 |
Normal-vs-Grade 3 |
1.90236715269521E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
3.637000E-01 |
Grade 1-vs-Grade 3 |
1.811710E-02 |
Grade 1-vs-Grade 4 |
9.65370000000076E-05 |
Grade 2-vs-Grade 3 |
1.700400E-03 |
Grade 2-vs-Grade 4 |
1.17549999734123E-08 |
Grade 3-vs-Grade 4 |
8.646100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.831700E-04 |
Normal-vs-ccB subtype |
2.91988655476416E-14 |
ccA subtype-vs-ccB subtype |
1.03989999999943E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.05130015803923E-10 |
Normal-vs-N1 |
6.16310000034481E-07 |
N0-vs-N1 |
1.333980E-01 |
|
|